A detailed history of Voya Investment Management LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 52,218 shares of OLMA stock, worth $320,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,218
Previous 31,472 65.92%
Holding current value
$320,096
Previous $340,000 83.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 07, 2025

BUY
$10.41 - $16.46 $215,965 - $341,479
20,746 Added 65.92%
52,218 $623,000
Q3 2024

Nov 14, 2024

BUY
$10.41 - $16.46 $215,965 - $341,479
20,746 Added 65.92%
52,218 $623,000
Q2 2024

Feb 07, 2025

SELL
$8.73 - $13.99 $856,543 - $1.37 Million
-98,115 Reduced 75.71%
31,472 $340,000
Q2 2024

Dec 03, 2024

SELL
$8.73 - $13.99 $181,112 - $290,236
-20,746 Reduced 39.73%
31,472 $340,000
Q2 2024

Aug 14, 2024

SELL
$8.73 - $13.99 $856,543 - $1.37 Million
-98,115 Reduced 75.71%
31,472 $340,000
Q1 2024

Feb 07, 2025

BUY
$10.95 - $16.62 $847,190 - $1.29 Million
77,369 Added 148.17%
129,587 $1.47 Million
Q1 2024

Dec 06, 2024

BUY
$10.95 - $16.62 $847,190 - $1.29 Million
77,369 Added 148.17%
129,587 $1.47 Million
Q1 2024

May 15, 2024

BUY
$10.95 - $16.62 $1.3 Million - $1.97 Million
118,486 Added 1067.35%
129,587 $1.47 Million
Q4 2023

Feb 07, 2025

BUY
$10.53 - $17.14 $2,716 - $4,422
258 Added 2.38%
11,101 $155,000
Q4 2023

Feb 14, 2024

BUY
$10.53 - $17.14 $2,716 - $4,422
258 Added 2.38%
11,101 $155,000
Q2 2023

Feb 07, 2025

SELL
$3.22 - $9.65 $133,227 - $399,268
-41,375 Reduced 79.24%
10,843 $97,000
Q2 2023

Aug 14, 2023

BUY
$3.22 - $9.65 $34,914 - $104,634
10,843 New
10,843 $97,000
Q4 2021

Feb 14, 2022

SELL
$8.75 - $30.71 $84,437 - $296,351
-9,650 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$22.96 - $30.13 $221,564 - $290,754
9,650 New
9,650 $266,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $248M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.